Aug 11, 2022
Marty Gauvin is the CEO and Co-Founder of Fertilis, an Australian-based company creating micro medical tools to be used in cell culture such as IVF to improve outcomes. There is a vast difference in outcomes of IVF across different clinics in part because of the human intervention that is required in the cell development process. Fertilis has developed a system that controls the environment around each cell and mimics what would happen in the body.
Marty explains, "The first way it makes it cheaper is simply by having one less cycle. Patients are not paying for a baby. Patients are paying for a cycle. And so if it takes one less cycle, the average at the moment is three cycles, if you could have a baby in two cycles, that's a very major saving. A saving well into the five figures that you're going to make in any marketing in the world."
"It further makes it efficient because, at the moment, IVF is so expensive because it's what the economist would call supply constraints. There aren't enough embryologists and IVF clinics for the number of people that would like to become parents. And so, by making the process more automated, we can make it so that the best embryologists are not required for every single cycle. We can make it possible for an embryologist to be trained in much less time, for example. So the constraint that's on that capacity can then be removed."
#Fertilis #IVF #IVFClinic #CellCulture #Embryologists #IncubatorMakers